Noema Pharma Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
Noema Pharma General Information
Description
Operator of a biotechnology company intended to address the disabling symptoms in orphan conditions of the central nervous system. The company offers novel therapies for conditions affecting the nervous system including diseases characterized by imbalanced neuronal networks, enabling medical professionals to improve quality of life and patient outcomes.
Contact Information
Website
www.noemapharma.comCorporate Office
- Barfüsserplatz 3
- 4051 Basel
- Switzerland
Corporate Office
- Barfüsserplatz 3
- 4051 Basel
- Switzerland
Noema Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 3. Later Stage VC (Series B) | 11-Dec-2024 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 01-Dec-2020 | $59.3M | $62.8M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 01-Jan-2019 | $3.53M | $3.53M | Completed | Pre-Clinical Trials |
Noema Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Preference | ||||||||
| S Preference |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Noema Pharma Comparisons
Industry
Financing
Details
Noema Pharma Competitors (4)
One of Noema Pharma’s 4 competitors is SAGE Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SAGE Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Minerva Neurosciences | Formerly VC-backed | Burlington, MA | ||||
| Voyager Therapeutics | Corporation | Lexington, MA |
Noema Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Noema Pharma Patents
Noema Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023226206-A1 | Triple uptake inhibitor for the treatment of atypical depression | Pending | 28-Feb-2022 | ||
| EP-4486337-A1 | Triple uptake inhibitor for the treatment of atypical depression | Pending | 28-Feb-2022 | ||
| AU-2022214289-A1 | Methods for the treatment of childhood-onset fluency disorder | Pending | 28-Jan-2021 | ||
| US-20230381193-A1 | Methods for the treatment of childhood-onset fluency disorder | Pending | 28-Jan-2021 | ||
| EP-4284381-A1 | Methods for the treatment of childhood-onset fluency disorder | Pending | 28-Jan-2021 | A61P25/18 |
Noema Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Noema Pharma Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Forbion | Venture Capital | Minority | ||
| Jeito | Growth/Expansion | Minority | ||
| UPMC Enterprises | Corporate Venture Capital | Minority | ||
| BioMedPartners | Venture Capital | Minority | ||
| Gilde Healthcare | Venture Capital | Minority |
Noema Pharma FAQs
-
When was Noema Pharma founded?
Noema Pharma was founded in 2019.
-
Where is Noema Pharma headquartered?
Noema Pharma is headquartered in Basel, Switzerland.
-
What is the size of Noema Pharma?
Noema Pharma has 34 total employees.
-
What industry is Noema Pharma in?
Noema Pharma’s primary industry is Drug Discovery.
-
Is Noema Pharma a private or public company?
Noema Pharma is a Private company.
-
What is Noema Pharma’s current revenue?
The current revenue for Noema Pharma is .
-
How much funding has Noema Pharma raised over time?
Noema Pharma has raised $210M.
-
Who are Noema Pharma’s investors?
Forbion, Jeito, UPMC Enterprises, BioMedPartners, and Gilde Healthcare are 5 of 9 investors who have invested in Noema Pharma.
-
Who are Noema Pharma’s competitors?
SAGE Therapeutics, ACADIA Pharmaceuticals, Minerva Neurosciences, and Voyager Therapeutics are competitors of Noema Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
